Skip to main content

and
  1. Article

    Open Access

    Epidermal growth factor receptor-mutant non-small cell lung Cancer and Choroidal metastases: long-term outcome and response to epidermal growth factor receptor tyrosine kinase inhibitors

    Choroidal metastases are the most common eye metastatic site. The prevalence of choroidal metastases in NSCLC patients has been reported to vary from 0.2 to 7% in historical series. Although previously reporte...

    Clémentine Bouchez, Johan Pluvy, Ghassen Soussi, Marina Nguenang in BMC Cancer (2020)

  2. No Access

    Article

    Clinicopathological and Molecular Study of Peritoneal Carcinomatosis Associated with Non-Small Cell Lung Carcinoma

    To retrospectively characterize the molecular features of Non-Small Cell Lung Carcinomas (NSCLC) with peritoneal carcinomatosis (PC), clinicopathological data of 12 patients diagnosed with NSCLC and PC between...

    Hussein Nassereddine, Aurélie Sannier, Solenn Brosseau in Pathology & Oncology Research (2020)

  3. Article

    Open Access

    NDR2 kinase contributes to cell invasion and cytokinesis defects induced by the inactivation of RASSF1A tumor-suppressor gene in lung cancer cells

    RASSF1A, a tumor suppressor gene, is frequently inactivated in lung cancer leading to a YAP-dependent epithelial-mesenchymal transition (EMT). Such effects are partly due to the inactivation of the anti-migrat...

    Maureen Keller, Fatéméh Dubois in Journal of Experimental & Clinical Cancer … (2019)

  4. Article

    Open Access

    MST1/Hippo promoter gene methylation predicts poor survival in patients with malignant pleural mesothelioma in the IFCT-GFPC-0701 MAPS Phase 3 trial

    The Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS/NCT00651456) phase 3 trial demonstrated the superiority of bevacizumab plus pemetrexed–cisplatin triplet over chemotherapy alone in 448 malignant pleur...

    Elodie Maille, Solenn Brosseau, Vincent Hanoux in British Journal of Cancer (2019)